An open labeled observational study of Vit K2-7(MK-7) in patients with Systremma (muscle cramps)

Viridis BioPharma Pvt Ltd0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Men & women with idiopathic muscle cramps (cramp will be defined as a painful contraction of any muscle group in the leg, which was either precipitated by certain movements, aborted by
•procedures involving stretch of the affected muscle or which was associated with a palpable
•hardening of the muscle. To qualify for trial inclusion, subjects should have a stable pattern of two or more cramps per week for three months.
•2. Willing to participate in the trial

•1. Subjects with physiological conditions causing cramps like pregnancy or during sports activity
•2. Patients with severe neurological, muscular, psychiatric, endocrinological, metabolic medical
•conditions or vascular diseases, electrolyte imbalance, liver cirrhosis causing muscle cramps will be excluded
•3. Subjects on drugs which are likely to affect muscle cramps
•4. Subjects with any known hypersensitivity to Vitamin K
•5. Patients with any cancers receiving chemotherapy/ radiation

发起方

Viridis BioPharma Pvt Ltd